Mediation by NF-κB of cytokine induced expression of intercellular adhesion molecule 1 (ICAM-1) in an intestinal epithelial cell line, a process blocked by proteasome inhibitors

Gut

Volumn 42, Issue 6, 1998, Pages 779-787

  Jobin, C ^a   Hellerbrand, C ^a   Licato, L L ^a   Brenner, D A ^a   Sartor, R B ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

Author keywords

Adhesion molecules; Cytokines; ICAM 1; Intestinal inflammation; NF B; Tumour necrosis factor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; PHOSPHOTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INFLAMMATION; INTESTINE EPITHELIUM; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION;

EID: 0031808369     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.42.6.779     Document Type: Article

References (59)

1. Sartor RB. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am 1995;24:475-507.
2. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-34.
3. Dippold W, Wittig B, Schwaeble W, et al. Expression of intracellular adhesion molecule 1 (ICAM-1) in colonic epithelial cells. Gut 1993;34:1593-7.
4. Kaiserlian D, Rigal D, Abello J, et al. Expression, function and regulation of the intercellular molecule-1 (ICAM-1) on human intestinal epithelial cell lines. Eur J Immunol 1991;21:2415-21.
5. Kvale D, Krajci P, Brandtaeg P. Expression and regulation of adhesion molecules ICAM-1 (CD54) and LFA-3 (CD58) in human intestinal cell lines. Scand J Immunol 1992;35: 669-76.
6. Huang T-JG, Eckmann L, Savidge TC, et al. Infection of human intestinal epithelial cells with invasive bacteria upregulates apical intercellular adhesion molecule-1 (ICAM-1) expression and neutrophil adhesion. J Clin Invest 1996;98:572-83.
7. Henninger DD, Panés J, Eppihimer M, et al. Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J Immunol 1997;158:1825-32.
8. Altmann DM, Hogg N, Trowsdale J, et al. Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells. Nature 1989;338: 512-14.
9. Dongworth DW, Gotch FM, Hildreth JEK, et al. Effects of monoclonal antibodies to the α and β chains of the human lymphocyte function-associated (H-LFA-1) antigen on T lymphocyte functions. Eur J Immunol 1985;15:888-92.
10. Douherty GJ, Murdoch S, Hogg N. The function of human intercellular adhesion molecule-1 (ICAM-1) in the generation of an immune response. Eur J Immunol 1988;18:35-9.
11. Makgoba MW, Sanders ME, Luce GEG, et al. Functional evidence that intercellular adhesion molecule-1 (ICAM-1) is a ligand for LFA-1-dependent adhesion in T cell-mediated cytotoxicity. Eur J Immunol 1988;18:637-40.
12. Colgan SP, Parkos CA, Delp C, et al. Neutrophil migration across cultured intestinal epithelial monolayers is modulated by epithelial exposure to IFN-γ in a highly polarized fashion. J Cell Biol 1993;120:785-98.
13. Yacyshyn B, Woloschuk B, Yacyshyn MB, et al. Efficacy and safety of ISIS 2302 (ICAM-1 antisense oligonucleotide) treatment of steroid-dependent Crohn's disease [abstract]. Gastroenterology 1997;112:A1123.
14. Collins T, Read MA, Neish AS, et al. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J 1995;9:899-908.
15. Ledebur HC, Parks TP. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. J Biol Chem 1995;270:933-43.
16. Grilli M, Chui JS, Lenardo MJ. NF-κB and Rel-participants in a multiform transcriptional regulatory system. Int Rev Cytol 1993;153:1-62.
17. Baeuerle PA, Henkle T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994;12:141-79.
18. Fan C-M, Maniatis T. Generation of p50 subunit of NF-κB by processing of p 105 through an ATP-dependent pathway. Nature 1991;354:395-8.
19. Baeuerle PA, Baltimore D. IκB: a specific inhibitor of the NF-κB transcription factor. Science 1988;242:540-6.
20. Beg AA, Finco TS, Nantermet PV, et al. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: a mechanism for NF-κB activation. Mol Cell Biol 1993;13:3301-10.
21. Henkel T, Machleidt T, Alkalay I, et al. Rapid proteolysis of IκB-α is necessary for activation of transcriptional factor NF-κ-B. Nature 1993;365:182-5.
22. Chen ZJ, Parent L, Maniatis T. Site-specific phosphorylation of IκBα by novel ubiquitination-dependent protein kinase activity. Cell 1996;84:853-62.
23. Palombella VJ, Rando OJ, Goldberg AL, et al. The ubiquitin-proeasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 1994;78:773-85.
24. Scherer DC, Brockman JA, Chen Z, et al. Signal-induced degradation of IκBα requires site-specific ubiquitination. Proc Natl Acad Sci USA 1995;92:11259-63.
25. Li C-CH, Dai R-M, Longo DL. Inactivation of NF-κB inhibitor IκBα: ubiquitin-dependent proteolysis and its degradation product. Biochem Biophys Res Commun 1995; 215:292-301.
26. Sun S-C, Ganchi PA, Ballard DW, et al. NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway. Science 1993;259:1912-15.
27. Jobin C, Haskill S, Mayer L, et al. Evidence for an altered regulation of IκBα degradation in human colonic epithelial cells. J Immunol 1997;158:226-34.
28. Jobin C, Panja A, Hellerbrand C, et al. Inhibition of proinflammatory molecule production by adenovirus-mediated expression of an NF-κB super-repressor in human intestinal epithelial cells. J Immunol 1998;160:410-18.
29. Rock KL, Gramm C, Rothstein L, et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on the MHC class I molecules. Cell 1994;78:761-71.
30. Figueiredo-Pereira ME, Banik N, Wilk S. Comparison of the effect of calpain inhibitors on two extralysosomal proteinases: the multicatalytic proteinase complex and m-calpain. J Neurochem 1994;62:1989-94.
31. Finco TS, Baldwin AS. Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity 1995;3:263-72.
32. Beauparlant P, Hiscott J. Biological and biochemical inhibitors of the NF-κB/Rel proteins and cytokine synthesis. Cytokine Growth Factor Rev 1996;7:175-90.
33. Cobb RR, Felts KA, Parry GCN, et al. Proteasome inhibitors block VCAM-1 and ICAM-1 gene expression in endothelial cells without affecting nuclear translocation of nuclear factor-κB. Eur J Immunol 1996;26:839-45.
34. Read MA, Neish AS, Luscinskas FW, et al. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity 1995;2: 493-506.
35. Jobin C, Gauthier J. Differential effects of cell density on 5-lipoxygenase (5-LO), 5-lipoxygenase-activating protein (FLAP) and interleukin-1β (IL-Iβ) expression in human neutrophils. Inflammation 1997;21:235-50.
36. Hellerbrand C, Wang SC, Tsukamoto H, et al. Expression of intercellular adhesion molecule 1 by activated hepatic stellate cells. Hepatology 1996;24:670-6.
37. Westwick JK, Brenner DA. Methods for analyzing c-Jun Kinase. Methods Enzymol 1995;255:342-59.
38. Lin Y-C, Brown K, Siebenlist U. Activation of NF-κB requires proteolysis of the inhibitor IκB-α: signal-induced phosphorylation of IκB-α alone does not release active NF-κB. Proc Natl Acad Sci USA 1995;92:552-6.
39. Miyamoto S, Maki M, Schmitt MJ, et al. Tumor necrosis factor α-induced phosphorylation of IκBα is a signal for its degradation but not dissociation from NF-κB. Proc Natl Acad Sci USA 1994;91:12740-4.
40. Whiteside ST, Ernst MK, Labail O, et al. N- and C-terminal control degradation of MAD3/IκBα in response to inducers of NF-κB activity. Mol Cell Biol 1995;15:5339-15.
41. Thanos D, Maniatis T. NF-κB: a lesson in family values. Cell 1995;30:529-32.
42. Finco TS, Beg AA, Baldwin ASJ. Inducible phosphorylation of IκBa is not sufficient for its dissociation from NF-κB and is inhibited by protease inhibitors. Proc Natl Acad Sci USA 1994;91:11884-8.
43. Kyriatis JM, Banerjee P, Nikolakaki E, et al. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 1994;369:156-60.
44. Westwick JK, Weitzel C, Minden A, et al. Tumor necrosis factor u stimulates AP-1 activity through prolonged activation of the c-Jun kinase. J Biol Chem 1994;269:26396-401.
45. Sluss HK, Barrett T, Derijard B, et al. Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol Cell Biol 1994;14:8376-84.
46. Hibi M, Lin A, Smeal T, et al. Identification of an oncoprotein and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 1993;7: 2135-48.
47. Derijard B, Hibi M, Wu I-H, et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994;76: 1025-38.
48. Hellerbrand C, Jobin C, Iimuro Y, et al. Inhibition of NF-κB in activated hepatic stellate cells by proteasome inhibitors and an IκB super-repressor. Hepatology 1998; (in press).
49. McGee DW, Baegley KW, Aicher WK, et al. Transforming growth factor-β and IL-1β act in synergy to enhance IL-6 secretion by the intestinal epithelial cell line, IEC-6. J Immunol 1993;151:970-8.
50. McGee DW, Bamberg T, Vitkus SJD, et al. A synergistic relationship between TNF-α, IL-1β, and TGF-β1 on IL-6 secretion by the IEC-6 intestinal epithelial cell line. Immunology 1995;86:6-11.
51. Nakamura S, Ohtani H, Watanabe Y, et al. In situ expression of the cell adhesion molecules in inflammatory bowel disease. Lab Invest 1993;69:77-85.
52. Madara JL, Patapoff TW, Gillece-Castro B, et al. 5′-adenosine monophosphate is the neutrophil-derived paracrine factor that elicits chloride secretion from T84 intestinal epithelial cells. J Clin Invest 1993;91:2320-5.
53. Panja A, Barone A, Mayer L. Stimulation of lamina propria lymphocytes by intestinal epithelial cells. J Exp Med 1994; 179:943-50.
54. Bennett CF, Kornbrust D, Henry S, et al. An ICAM-1 antisence oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice. J Pharmacol Exp Ther 1997;280:988-1000.
55. Rogler G, Vogl D, Brand K, et al. Transcription factor nuclear-kappa B is activated in macrophages and epithelial cells of inflamed intestinal mucosal [abstract]. Gastroenterology 1997;112:A1086.
56. Schreiber S, Hampe J, Nikolaus S, et al. Patterns of cytokine transcription factor activation are different in Crohn's disease (CD) and ulcerative colitis (UC) [abstract]. Gastroenterology 1997;112:A1086.
57. Oppenheim JJ, Zachariae COC, Mukaida N, et al. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 1991;9:617-48.
58. Conner EM, Brand S, Grisham MB. Inhibition of chronic granulomatous colitis by a selective proteasome inhibitor: antagonist of nuclear transcription factor κB(NF-κB) activation [abstract]. Gastroenterology 1996;110:A887.
59. Neurath M, Pettersson S, Meyer Zum Buschenfelde K-H, et al. Local administration of antisense phosphothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice. Nature Med 1996; 2:998-1004.